Ovarian cancer is a silent killer, affecting women all over the world. Although ovarian cancer is a rare disease, it ranks as the fifth-leading cause of cancer deaths among women in the United States, with more than 22,000 new cases diagnosed each year.

Currently, there are no effective screening methods for ovarian cancer, and most women are diagnosed after the disease has already spread to other parts of the body. While there is no known cure for ovarian cancer, researchers have been working tirelessly for years to identify ways to prevent the illness or catch it at an earlier stage.

One promising development in this regard has been the emergence of new generation contraceptives that may lower the risk of ovarian cancer.

What are new generation contraceptives?

New generation contraceptives refer to a range of birth control options that have emerged in recent years. These include contraceptive intrauterine devices (IUDs), contraceptive hormone patches, vaginal rings, and progestin-only pills.

These contraceptives differ from traditional birth control methods in that they contain hormones that are more in tune with a woman’s natural hormone levels. Additionally, these contraceptives deliver hormones directly to the uterus and ovaries, which may help to prevent the development of ovarian cancer.

How do new generation contraceptives work?

New generation contraceptives work by releasing hormones that either prevent ovulation, thicken cervical mucus to prevent sperm from reaching the egg, or thin the lining of the uterus to prevent implantation.

Specifically, these contraceptives contain synthetic versions of either estrogen and progestin or progestin alone that work to prevent the release of the hormone that triggers ovulation. Without ovulation, there is no egg to fertilize and no pregnancy can occur.

By regulating a woman’s menstrual cycle, new generation contraceptives can reduce the risk of ovarian cancer by preventing the overexposure to certain hormones that can lead to tumor development.

How effective are new generation contraceptives in preventing ovarian cancer?

Studies have shown that women who use new generation contraceptives have a lower risk of developing ovarian cancer than women who do not use any form of birth control.

One study found that women who used oral contraceptives that contained both estrogen and progestin for at least three years had a 30–50% lower risk of developing ovarian cancer. Another study found that women who used progestin-only contraceptives had a 40% lower risk of developing ovarian cancer.

While the studies are not conclusive, they do suggest that new generation contraceptives may be an effective tool in the fight against ovarian cancer.

How long do you need to use new generation contraceptives to reduce ovarian cancer risk?

The length of time that a woman needs to use new generation contraceptives to reduce her risk of ovarian cancer varies depending on the type of contraceptive she is using.

For example, women who use oral contraceptives that contain both estrogen and progestin for at least three years have been shown to have a significant reduction in ovarian cancer risk. However, women who use progestin-only contraceptives must use them for longer periods of time to achieve the same risk reduction.

Are there any risks associated with new generation contraceptives?

Like any form of medication, there are risks associated with new generation contraceptives. Some women who use these contraceptives experience side effects such as weight gain, mood changes, and irregular periods.

Additionally, there is a very small risk of blood clots and strokes associated with new generation contraceptives. However, the benefits of using these contraceptives in terms of reducing ovarian cancer risk far outweigh the potential risks.

What should women do if they are concerned about their ovarian cancer risk?

If you are concerned about your ovarian cancer risk, you should talk to your healthcare provider about your options.

Your provider can help you determine whether new generation contraceptives are a good choice for you and can discuss the potential risks and benefits of these contraceptives in detail. Additionally, your healthcare provider can advise you on other steps you can take to reduce your risk of ovarian cancer, such as maintaining a healthy lifestyle and getting regular check-ups.

Conclusion

Ovarian cancer is a serious disease that affects thousands of women worldwide. While there is no known cure for ovarian cancer, researchers have made significant progress in identifying ways to prevent the disease.

One promising development in this regard has been the emergence of new generation contraceptives that may lower the risk of ovarian cancer. If you are concerned about your ovarian cancer risk, talk to your healthcare provider about whether new generation contraceptives are a good choice for you.